A multistage tuberculosis vaccine that confers efficient protection before and after exposure
Nature Medicine2011Vol. 17(2), pp. 189–194
Citations Over TimeTop 1% of 2011 papers
Claus Aagaard, Truc Thi Kim Thanh Hoang, Jes Dietrich, Père-Joan Cardona, Angelo Izzo, Gregory Dolganov, Gary K. Schoolnik, Joseph P. Cassidy, Rolf Billeskov, Peter Andersen
Related Papers
- → Construction, characterization and preclinical evaluation of MTBVAC, the first live-attenuated M. tuberculosis-based vaccine to enter clinical trials(2013)257 cited
- → A novel liposomal adjuvant system, CAF01, promotes long-lived Mycobacterium tuberculosis-specific T-cell responses in human(2014)239 cited
- → Adjuvant formulation structure and composition are critical for the development of an effective vaccine against tuberculosis(2013)103 cited
- → Novel adjuvant formulations for delivery of anti-tuberculosis vaccine candidates(2015)58 cited
- → Safety and Immunogenicity of a New Tuberculosis Vaccine, MVA85A, in Mycobacterium tuberculosis–infected Individuals(2009)7 cited